NL-OMON40930已完成4 期
A study to assess the anti-albuminuric effects and variability in response to dapagliflozin in subjects with type 2 diabetes - Anti-albuminuric effects and response variability to dapagliflozin
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >=18 and <=75 years
- •Diagnosis of type 2 diabetes mellitus
- •HbA1c >= 6.6% and <11.0%
- •Urinary albumin excretion > 100 mg/g
- •On a stable dose of an ACEi or ARB for at least 4 weeks prior to randomization
- •On a stable dose of blood glucose lowering medication for at least 4 weeks prior to randomization
- •eGFR >= 45 mL/min/1.73m2
- •Willing to sign informed consent
排除标准
- •Type 1 diabetes
- •Urinary albumin excretion > 3500 mg/day
- •Active malignancy
- •Pregnancy or breast feeding
研究者
相似试验
进行中（未招募）
不适用
A study to examine whether the glucose lowering medicine dapagliflozin decreases urinary protein excretion and to determine the variation in response to dapagliflozin in plasma glucose / urinary protein excretion / blood pressure between and within patients.Patients with type 2 diabetes and albuminuria between 100 and 3500 mg/g.EUCTR2014-000157-37-NLniversity Medical Center Groningen
尚未招募
不适用
IMPROVEType 2 diabetesHigh AlbuminuriaNL-OMON23733niversity Medical Center Groningen36
尚未招募
4 期
Comparing Medications for Reducing Kidney Damage in Diabetes: A Study on Dapagliflozin Alone and with EplerenoneCTRI/2024/01/061952Dr Nikhil Kumar
已完成
2 期
Investigating the effect of Albumin on urine output, using it with lasix and mannitol in ICU patients with oliguriaAcute renal failure.Acute renal failure, unspecifiedIRCT2016013010741N3Vice chancellor for research, Kerman University of Medical Sciences100
招募中
2 期
The effect of albumin administration on mortality rate, lung involvement rate and blood oxygen in patients with covid-19 hospitalized in the intensive care unitIRCT20221011056144N1Karaj University of Medical Sciences52